Here are six articles published by Becker's Hospital Review this week, highlighting President Donald Trump's executive order on drug pricing, Amazon's acquisition of Whole Foods and more.
1. Lucid Pharma recalls 69k bottles of antidepressant over quality issues
Lucid Pharmaceuticals recalled more than 69,000 bottles of its extended-release antidepressant drug cenlafaxine hydrochloride over quality concerns.
2. 4 things to know about Trump's executive order on drug pricing
A draft of President Donald Trump's executive order on drug prices lists several proposals to roll back regulatory hurdles for the pharmaceutical industry.
3. 25 top supply chains in 2017, as ranked by Gartner
London-based Unilever manages the highest-performing supply chain this year, according to Gartner's 2017 Supply Chain Top 25 list.
4. Hospira recall exacerbates ongoing baking soda shortage: 4 things to know
Hospira recalled 42 lots of sodium bicarbonate solution last week over potential issues with their sterility, worsening an ongoing critical shortage of the crucial drug.
5. Whole Foods acquisition could move Amazon closer to pharmacies
Amazon's $13.7 billion acquisition of Whole Foods may help the company enter the pharmacy market.
6. Improving receivables a top priority for 45% of healthcare supplier finance execs
Eighty-eight percent of finance executives at healthcare suppliers anticipate pressure to improve cash and working capital performance will grow during the next year, a Global Healthcare Exchange survey found.
More articles on supply chain:
Lucid Pharma recalls 69k bottles of antidepressant over quality issues
Why this drugmaker invests in clean coal
FDA approves Shire's ADHD drug: 3 things to know